OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting epigenetic reader domains by chemical biology
Alessandra Cipriano, Gianluca Sbardella, Alessio Ciulli
Current Opinion in Chemical Biology (2020) Vol. 57, pp. 82-94
Closed Access | Times Cited: 25
Alessandra Cipriano, Gianluca Sbardella, Alessio Ciulli
Current Opinion in Chemical Biology (2020) Vol. 57, pp. 82-94
Closed Access | Times Cited: 25
Showing 25 citing articles:
Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein Inhibitors
Peng‐Hsun Chase Chen, Xuejiao Shirley Guo, Hanyuan Eric Zhang, et al.
ACS Central Science (2024)
Open Access | Times Cited: 8
Peng‐Hsun Chase Chen, Xuejiao Shirley Guo, Hanyuan Eric Zhang, et al.
ACS Central Science (2024)
Open Access | Times Cited: 8
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity
M. Honer, Benjamin Ferman, Zach H. Gray, et al.
Genes & Development (2024) Vol. 38, Iss. 11-12, pp. 473-503
Open Access | Times Cited: 7
M. Honer, Benjamin Ferman, Zach H. Gray, et al.
Genes & Development (2024) Vol. 38, Iss. 11-12, pp. 473-503
Open Access | Times Cited: 7
Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors
Yi Zhang, Deqin Rong, Bingbing Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7900-7925
Closed Access | Times Cited: 37
Yi Zhang, Deqin Rong, Bingbing Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7900-7925
Closed Access | Times Cited: 37
Deciphering the PTM codes of the tumor suppressor p53
Jia Wen, Donglai Wang
Journal of Molecular Cell Biology (2021) Vol. 13, Iss. 11, pp. 774-785
Open Access | Times Cited: 32
Jia Wen, Donglai Wang
Journal of Molecular Cell Biology (2021) Vol. 13, Iss. 11, pp. 774-785
Open Access | Times Cited: 32
Chemical tools targeting readers of lysine methylation
Gloria Ortiz, Tatiana G. Kutateladze, Danica Galonić Fujimori
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102286-102286
Open Access | Times Cited: 12
Gloria Ortiz, Tatiana G. Kutateladze, Danica Galonić Fujimori
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102286-102286
Open Access | Times Cited: 12
Successes and challenges in the development of BD1-selective BET inhibitors: a patent review
Monica Viviano, Alessandra Cipriano, Emanuele Fabbrizi, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 7, pp. 529-545
Closed Access | Times Cited: 4
Monica Viviano, Alessandra Cipriano, Emanuele Fabbrizi, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 7, pp. 529-545
Closed Access | Times Cited: 4
Integrative Chemical Biology Approaches to Deciphering the Histone Code: A Problem-Driven Journey
Xin Li, Xiang Li
Accounts of Chemical Research (2021) Vol. 54, Iss. 19, pp. 3734-3747
Closed Access | Times Cited: 25
Xin Li, Xiang Li
Accounts of Chemical Research (2021) Vol. 54, Iss. 19, pp. 3734-3747
Closed Access | Times Cited: 25
DMSO‐Related Effects on Ligand‐Binding Properties of Lysine Methyltransferases G9a and SETD8
Alessandra Feoli, Giuliana Sarno, Sabrina Castellano, et al.
ChemBioChem (2024) Vol. 25, Iss. 4
Open Access | Times Cited: 3
Alessandra Feoli, Giuliana Sarno, Sabrina Castellano, et al.
ChemBioChem (2024) Vol. 25, Iss. 4
Open Access | Times Cited: 3
Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks
Sha Liu, Xiang Li, Xin Li, et al.
Current Opinion in Chemical Biology (2023) Vol. 75, pp. 102334-102334
Closed Access | Times Cited: 8
Sha Liu, Xiang Li, Xin Li, et al.
Current Opinion in Chemical Biology (2023) Vol. 75, pp. 102334-102334
Closed Access | Times Cited: 8
Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors
Rezaul M. Karim, Melissa J. Bikowitz, A. Chan, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 21, pp. 15772-15786
Open Access | Times Cited: 18
Rezaul M. Karim, Melissa J. Bikowitz, A. Chan, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 21, pp. 15772-15786
Open Access | Times Cited: 18
Photo-Cross-Linking To Delineate Epigenetic Interactome
Zhuoyuan Zhang, Jianwei Lin, Zheng Liu, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 46, pp. 20979-20997
Closed Access | Times Cited: 13
Zhuoyuan Zhang, Jianwei Lin, Zheng Liu, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 46, pp. 20979-20997
Closed Access | Times Cited: 13
Targeting the epigenetic reader “BET” as a therapeutic strategy for cancer
Abhishek Wahi, Namish Manchanda, Priti Jain, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106833-106833
Closed Access | Times Cited: 7
Abhishek Wahi, Namish Manchanda, Priti Jain, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106833-106833
Closed Access | Times Cited: 7
Marton I. Siklos, Stefan Kubicek
FEBS Journal (2021) Vol. 289, Iss. 5, pp. 1276-1301
Open Access | Times Cited: 17
Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity
Xianghong Guan, Narsihmulu Cheryala, Rezaul M. Karim, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10441-10458
Closed Access | Times Cited: 11
Xianghong Guan, Narsihmulu Cheryala, Rezaul M. Karim, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10441-10458
Closed Access | Times Cited: 11
Transcriptional control of leukemogenesis by the chromatin reader SGF29
Karina Barbosa, Anagha Deshpande, Marlenne Perales, et al.
Blood (2023) Vol. 143, Iss. 8, pp. 697-712
Closed Access | Times Cited: 6
Karina Barbosa, Anagha Deshpande, Marlenne Perales, et al.
Blood (2023) Vol. 143, Iss. 8, pp. 697-712
Closed Access | Times Cited: 6
Chemogenomics for drug discovery: clinical molecules from open access chemical probes
Robert Quinlan, Paul E. Brennan
RSC Chemical Biology (2021) Vol. 2, Iss. 3, pp. 759-795
Open Access | Times Cited: 15
Robert Quinlan, Paul E. Brennan
RSC Chemical Biology (2021) Vol. 2, Iss. 3, pp. 759-795
Open Access | Times Cited: 15
Discovery of Benzo[d]imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain
Alessandra Cipriano, Ciro Milite, Alessandra Feoli, et al.
ChemMedChem (2022) Vol. 17, Iss. 20
Open Access | Times Cited: 10
Alessandra Cipriano, Ciro Milite, Alessandra Feoli, et al.
ChemMedChem (2022) Vol. 17, Iss. 20
Open Access | Times Cited: 10
Histone code reader SPIN1 is a promising target of cancer therapy
Di Li, Jihua Guo, Rong Jia
Biochimie (2021) Vol. 191, pp. 78-86
Open Access | Times Cited: 13
Di Li, Jihua Guo, Rong Jia
Biochimie (2021) Vol. 191, pp. 78-86
Open Access | Times Cited: 13
Small-Molecule Inhibitors of the MLL1 CXXC Domain, an Epigenetic Reader of DNA Methylation
Hanuman P. Kalmode, Izabella Podsiadly, Ashish Kabra, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 8, pp. 1363-1369
Open Access | Times Cited: 9
Hanuman P. Kalmode, Izabella Podsiadly, Ashish Kabra, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 8, pp. 1363-1369
Open Access | Times Cited: 9
Enhanced cellular death in liver and breast cancer cells by dual BET /BRPF1 inhibitors
Giulia Cazzanelli, Andrea Dalle Vedove, Nicolò Sbardellati, et al.
Protein Science (2024) Vol. 33, Iss. 11
Open Access | Times Cited: 1
Giulia Cazzanelli, Andrea Dalle Vedove, Nicolò Sbardellati, et al.
Protein Science (2024) Vol. 33, Iss. 11
Open Access | Times Cited: 1
Targeting the Acetylation Reader Family: Bromodomain Proteins
Martin P. Schwalm, Atoosa Karimi Babaahmadi, Suzanne Ackloo, et al.
Royal Society of Chemistry eBooks (2024), pp. 404-439
Closed Access
Martin P. Schwalm, Atoosa Karimi Babaahmadi, Suzanne Ackloo, et al.
Royal Society of Chemistry eBooks (2024), pp. 404-439
Closed Access
Targeting Epigenetic Readers Using Small Molecule Binders and PROTAC Degraders
Eleonora Boccia, Erica Gazzillo, Maria Giovanna Chini, et al.
Interdisciplinary cancer research (2024)
Closed Access
Eleonora Boccia, Erica Gazzillo, Maria Giovanna Chini, et al.
Interdisciplinary cancer research (2024)
Closed Access
Drug Discovery for Chromatin Readers, Writers, Erasers, Remodelers and Epitranscriptomic Targets
Royal Society of Chemistry eBooks (2024)
Closed Access
Royal Society of Chemistry eBooks (2024)
Closed Access
Polypharmacology in Predicting Drug Toxicity: Drug Promiscuity
Zhiguo Wang, Baofeng Yang
Springer eBooks (2022), pp. 593-623
Closed Access | Times Cited: 1
Zhiguo Wang, Baofeng Yang
Springer eBooks (2022), pp. 593-623
Closed Access | Times Cited: 1
High Density Domain-Focused CRISPR Screens Reveal Novel Epigenetic Regulators ofHOX/MEISActivation in Acute Myeloid Leukemia
Karina Barbosa, Anagha Deshpande, Marlenne Perales, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Karina Barbosa, Anagha Deshpande, Marlenne Perales, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
